🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
There will be 2 phases in this study. Patients will either be enrolled to t...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Start Date
2006-09
Trial ID
NCT00402116
Treatments Being Tested
The purpose of this surveillance is to collect more safety and efficacy dat...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00704808
Treatments Being Tested
The goal of this clinical research study is to learn if the combination of ...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2003-09
Trial ID
NCT00504660
Treatments Being Tested
The purpose of this study is to better define longitudinal genomic alterati...
Status
Suspended
Location
The Preston Robert Tisch Brain Tumor Center at Duke University
Start Date
2023-04-18
Trial ID
NCT05695976
The goal of this clinical trial is to learn if a combined treatment approac...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine
Start Date
2025-04-01
Trial ID
NCT07193654
The primary protocol objective is to assess the impact of substituting puls...
Status
Active Not Recruiting
Location
Medical College of Wisconsin
Start Date
2021-06-03
Trial ID
NCT04747145
Treatments Being Tested
The overall objective of this study is to preliminarily evaluate the effica...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-30
Trial ID
NCT07715097
Treatments Being Tested
This clinical trial evaluates adding high-dose ascorbate (vitamin C) to sta...
Status
Active Not Recruiting
Location
Holden Comprehensive Cancer Center
Start Date
2017-03-13
Trial ID
NCT02344355
Treatments Being Tested
Cilengitide 2000 mg flat i.v. twice weekly is administered over a period of...
Status
Unknown
Location
Royal North Shore Hospital
Start Date
2009-11
Trial ID
NCT01124240
Treatments Being Tested
This is a phase II study of Bevacizumab plus Temodar and Tarceva in patient...
Status
Completed
Location
University of California San Francisco
Start Date
2007-09
Trial ID
NCT00525525
Treatments Being Tested